Sorafenib in recurrent and/or metastatic salivary gland carcinomas (RMSGCs): An investigator-initiated phase II trial (NCT01703455)

Locati, Ld; Bossi, P; Civelli, Em; Perrone, F; Bergamini, C; Cortelazzi, B; Quattrone, P; Imbimbo, M; Mirabile, A; Granata, R; Resteghini, C; Mariani, L; Tosarello, D; Cassani, C; Marchiano', A; Saibene, G; Pilotti, S; Licitra, Lf